AYRTON DRUG was incorporated on the 24th September 1965 by the Late Mr. Samuel Benson Adjapong; a Ghanaian entrepreneur and the first Ghanaian Chief Pharmacist at the Ministry of Health. From humble beginnings at Kokomlemle, with a staff strength of only 10, it moved to its current location on the Abeka Road, Tesano in Accra in 1969.
Over the years, despite the adverse economic conditions, Ayrton has kept alive the hope of becoming a force in the pharmaceutical industry in Ghana with about 30 product lines.
AYRTON adapted quickly to the dynamics of the local business environment and with careful planning, managed to substantially upgrade its plant, machinery and product lines to its present status.
Dannex Limited is the majority shareholder in both Starwin Products (71.33%) and Ayrton Drug (53.47%) Dannex intends to merge the three companies into one formidable company, both operationally and legally. The purpose of the merger is to create synergies and scale to be able to compete effectively and profitably in Ghana and West Africa. The best of the three companies would be put together to produce high quality and value for money medicines that would meet customer and consumer needs.